Eli Lilly and Company announced the FDA approval of Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin, indicated along with diet and exercise to control high blood sugar in adults… read more.
Communicating normal test results that reveal no abnormalities isn’t always enough to ease a patient’s worries. In this study, researchers asked 349 participants to imagine having gastrointestinal symptoms… read more.
Pharmacies that receive federal funds must provide language support to make sure patients can understand their medication instructions. A survey of 169 outpatient prescribers at a large academic… read more.
Eli Lilly and Company announced results from a new analysis showing that Zepbound (tirzepatide) 10 mg and 15 mg, a dual GIP and GLP-1 receptor agonist, delivered greater… read more.
Pharming announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) seeking approval for lower doses of Joenja (leniolisib), an oral,… read more.
Emergency medicine physician-researchers at the University of Cincinnati have shown that a targeted quality improvement campaign can safely reduce unnecessary head and cervical spine (neck) computed tomography (CT) scans in… read more.
Dr. Wendy Harpham was 36 years old and a successful physician who prided herself on her empathy. Then she was diagnosed with cancer. Seeing things from the other… read more.
AstraZeneca’s fixed-dose triple-combination Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate or BGF (320/28.8/10μg)) has been approved in the European Union (EU) as a maintenance treatment for asthma in patients 12… read more.
AbbVie announced today that new data from its broad multiple myeloma research portfolio will be featured at the 23rd International Myeloma Society (IMS) Annual Meeting, taking place September… read more.
Exercise-based cardiac rehabilitation reduces hospital admissions by a third and heart attack risk by more than a quarter, as well as remaining beneficial in the long term, a… read more.
“Fear and pain — together referred to as distress — are among the most common negative effects of vaccine injections,” says Dr. Anna Taddio, Leslie Dan Faculty of Pharmacy, University of… read more.
Lantheus Holdings announced that the FDA has granted final approval for Bravnetsa (lutetium Lu 177 dotatate), a bioequivalent and therapeutically equivalent radiopharmaceutical to Lutathera (lutetium Lu 177 dotatate)…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
